JP2009539362A - Gタンパク質共役型受容体39(gpr39) - Google Patents
Gタンパク質共役型受容体39(gpr39) Download PDFInfo
- Publication number
- JP2009539362A JP2009539362A JP2009513702A JP2009513702A JP2009539362A JP 2009539362 A JP2009539362 A JP 2009539362A JP 2009513702 A JP2009513702 A JP 2009513702A JP 2009513702 A JP2009513702 A JP 2009513702A JP 2009539362 A JP2009539362 A JP 2009539362A
- Authority
- JP
- Japan
- Prior art keywords
- gpr39
- seq
- compound
- nucleic acid
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
- G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/044—Hyperlipemia or hypolipemia, e.g. dyslipidaemia, obesity
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Obesity (AREA)
- Biochemistry (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Heart & Thoracic Surgery (AREA)
- Rehabilitation Therapy (AREA)
- Vascular Medicine (AREA)
- Rheumatology (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06115158 | 2006-06-08 | ||
PCT/EP2007/055636 WO2007141322A1 (fr) | 2006-06-08 | 2007-06-08 | Récepteur couplé à la protéine g 39 (gpr39) |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2009539362A true JP2009539362A (ja) | 2009-11-19 |
Family
ID=37198919
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2009513702A Ceased JP2009539362A (ja) | 2006-06-08 | 2007-06-08 | Gタンパク質共役型受容体39(gpr39) |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP2030024A1 (fr) |
JP (1) | JP2009539362A (fr) |
CN (1) | CN101467047A (fr) |
CA (1) | CA2652398A1 (fr) |
MX (1) | MX2008015670A (fr) |
WO (1) | WO2007141322A1 (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP4070797A4 (fr) * | 2019-11-01 | 2023-11-29 | Peking University | Utilisation d'acides biliaires et de dérivés de ceux-ci dans la préparation d'un agoniste gpr39 |
US20230174484A1 (en) | 2020-04-30 | 2023-06-08 | Oregon Health & Science University | Antagonists of gpr39 protein |
KR20240093844A (ko) | 2021-10-26 | 2024-06-24 | 바소카데아, 인코포레이티드 | Gpr39 단백질의 길항제 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001081634A2 (fr) * | 2000-04-26 | 2001-11-01 | Millennium Pharmaceuticals, Inc. | Methodes et compositions destinees au diagnostic et au traitement des maladies cardio-vasculaires et tumorigenes a l'aide de 4941 |
US20030232769A1 (en) * | 2002-06-17 | 2003-12-18 | Isis Pharmaceuticals Inc. | Antisense modulation of G protein-coupled receptor 39 expression |
US20040071708A1 (en) * | 2002-09-26 | 2004-04-15 | Immusol, Inc. | GPR 39 modulators that control cancerous cell growth |
WO2004039837A2 (fr) * | 2002-10-31 | 2004-05-13 | Janssen Pharmaceutica N.V. | Genes reagissant a l'hormone liberatrice de la corticotropine dans le systeme nerveux central |
WO2004097411A1 (fr) * | 2003-04-25 | 2004-11-11 | Takeda Pharmaceutical Company Limited | Nouvelle methode de criblage |
EP1623230A2 (fr) * | 2003-05-05 | 2006-02-08 | Bayer HealthCare AG | Approche diagnostique et therapeutique des maladies associees au recepteur gpr39 (gpr39) couple a une proteine g |
CN101107529A (zh) * | 2004-12-01 | 2008-01-16 | 詹森药业有限公司 | G蛋白偶联受体 |
-
2007
- 2007-06-08 EP EP07729995A patent/EP2030024A1/fr not_active Withdrawn
- 2007-06-08 CN CNA2007800212075A patent/CN101467047A/zh active Pending
- 2007-06-08 MX MX2008015670A patent/MX2008015670A/es unknown
- 2007-06-08 WO PCT/EP2007/055636 patent/WO2007141322A1/fr active Application Filing
- 2007-06-08 CA CA002652398A patent/CA2652398A1/fr not_active Abandoned
- 2007-06-08 JP JP2009513702A patent/JP2009539362A/ja not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
WO2007141322A1 (fr) | 2007-12-13 |
EP2030024A1 (fr) | 2009-03-04 |
CN101467047A (zh) | 2009-06-24 |
MX2008015670A (es) | 2009-01-12 |
CA2652398A1 (fr) | 2007-12-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2006523440A (ja) | 若年性ヘモクロマトーシス遺伝子(hfe2a)、その発現産物および使用法 | |
EP1377834A2 (fr) | Medicaments modulateurs de hm74 et/ou de l'activite de hm74a | |
US20100168014A1 (en) | Screening method | |
JPH11169187A (ja) | 新規化合物 | |
JP2009539362A (ja) | Gタンパク質共役型受容体39(gpr39) | |
WO2000035954A1 (fr) | Recepteur couple de proteine g humaine | |
JP2008521419A (ja) | Gタンパク質共役型受容体 | |
JPH1175870A (ja) | 新規なヒトg−タンパク質結合レセプター(hcept09) | |
EP1255779A2 (fr) | Identification de modulateurs de l'activite gpr41 ou gpr42 | |
WO2005121356A1 (fr) | Nouveau procédé de recherche par criblage | |
JP4638354B2 (ja) | G蛋白質共役型受容体をコードする遺伝子およびその遺伝子産物 | |
CA2404679C (fr) | Recepteur couple aux proteines-g | |
JP2006290826A (ja) | スクリーニング方法 | |
EP2575860A1 (fr) | Applications de diagnostic, de dépistage et thérapeutiques d'outils à base de la protéine ocab | |
KR20090111346A (ko) | 이피에프 수용체 에세이, 화합물 및 치료학적 조성물 | |
EP1484396B1 (fr) | Molecules s'associant au domaine terminal c dans une cellule receptrice | |
EP3528831B1 (fr) | Utilisation de polypeptides et d'acides nucléiques fkbp-l servant au traitement de l'obésité | |
JPWO2005093068A1 (ja) | 新規タンパク質及びプロモーター | |
EP1945661B1 (fr) | Récepteur gpr 146 | |
WO2006118289A1 (fr) | Procede pour l’identification d’un compose ayant un effet antidepresseur | |
JPWO2003080831A1 (ja) | 核内受容体ERRγ3 | |
TW201131168A (en) | Methods and compositions for identifying modulators of G protein-coupled receptors | |
JP2002504493A (ja) | Mucilage、Gタンパク質共役型受容体 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A045 | Written measure of dismissal of application |
Free format text: JAPANESE INTERMEDIATE CODE: A043 Effective date: 20100126 |